Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Rixubis Market Report 2025

Rixubis Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Type (Recombinant Factor IX, Plasma-derived Factor IX), By Indication (Routine Prophylaxis, Treatment Of Bleeding Episodes, Peri-Operative Management), By Application (Hemophilia B Treatment, Surgical Procedures), By End User (Pediatric, Adult, Geriatric)

Rixubis Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Rixubis Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Rixubis Market Definition

Rixubis is a recombinant factor IX therapy developed for the treatment and prevention of bleeding episodes in individuals with hemophilia B. It is designed to replace the missing or deficient factor IX in patients, helping to achieve better bleeding control and improved quality of life.

The main types of rixubis are recombinant factor IX and plasma-derived factor IX. Recombinant Factor IX is a genetically engineered protein used to treat hemophilia B by replacing the deficient or missing clotting factor IX in the blood. It is used in indications such as routine prophylaxis, treatment of bleeding episodes, and peri-operative management, supporting both hemophilia B treatment and surgical procedures. The users of this treatment include pediatric, adult, and geriatric patients.

Rixubis Market Segmentation

The rixubis market covered in this report is segmented –

1) By Type: Recombinant Factor IX; Plasma-derived Factor IX

2) By Indication: Routine Prophylaxis; Treatment Of Bleeding Episodes; Peri-Operative Management

3) By Application: Hemophilia B Treatment; Surgical Procedures

4) By End User: Pediatric; Adult; Geriatric

Rixubis Market Size and growth rate 2025 to 2029: Graph

Rixubis Market Size 2025 And Growth Rate

The rixubis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rise in the prevalence of hemophilia B, an increase in awareness about genetic bleeding disorders, growth in the number of diagnostic centers, improved healthcare infrastructure, and early adoption of replacement therapies.

Rixubis Market Growth Forecast

The rixubis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing demand for recombinant therapies, increasing focus on personalized medicine, government initiatives to improve rare disease management, improved affordability of advanced treatments, and enhanced diagnostic accuracy for genetic disorders. Major trends in the forecast period include increasing adoption of long-acting recombinant products, growing preference for home-based treatment solutions, advancements in delivery mechanisms, development of cost-effective biosimilars, and integration of digital health tools for patient monitoring.

Book your 30 minutes free consultation with our research experts

Contact Us

Rixubis Market Driver: Growing Hemophilia Cases Increase Need For Effective Bleeding Disorder Treatments

The increasing incidence of hemophilia is expected to drive the growth of the rixubis market going forward. Hemophilia is a genetic bleeding disorder that affects the blood’s ability to clot, leading to prolonged bleeding episodes. Hemophilia is increasing due to advancements in diagnostic techniques, improved awareness, and population growth, leading to the identification of more cases worldwide. Rixubis helps manage hemophilia by providing a recombinant factor IX therapy that aids in preventing and controlling bleeding episodes, enabling individuals with hemophilia B to maintain better overall health and reduce the risk of complications associated with clotting deficiencies. For instance, in November 2022, according to the report published by the United Kingdom Hemophilia Centre Doctors’ Organization (UKHCDO), a UK-based medical association, the new registrations of Hemophilia A in the United Kingdom in 2021 were 16, which increased to 19 in 2022. Therefore, the increasing incidence of hemophilia is driving the growth of the rixubis market.

Rixubis Market Driver: Rising Bleeding Disease Incidence Boosts Demand For Hemophilia B Treatments

Increasing incidence of bleeding diseases is expected to propel the growth of the rixubis market going forward. Bleeding diseases refer to a group of disorders that affect the blood’s ability to clot properly, leading to excessive bleeding. The prevalence of bleeding diseases is increasing due to factors including better diagnosis, genetic predispositions, and rising awareness of these conditions. Rixubis helps bleeding diseases by delivering a recombinant factor IX therapy that supports effective blood clot formation, reducing the frequency and severity of bleeding episodes, and improving the quality of life for individuals with clotting disorders such as hemophilia B. For instance, in December 2022, according to the report published by the United Kingdom Hemophilia Centre Doctors' Organization (UKHCDO), a UK-based organization, in 2021/22, at least 4,123 males and 11,288 females with von Willebrand disease were registered and treated by doctors managing bleeding disorders, including 371 new cases in 2022, 12% of which had no reported subtype. Therefore, the increasing incidence of bleeding diseases is driving the growth of the rixubis market.

Rixubis Market Driver: Impact Of Increasing Healthcare R&D Funding On The Growth Of The Market

The increasing amount of healthcare research and development funding is expected to propel the growth of the rixubis market going forward. Research and development (R&D) funding refers to the financial resources allocated for advancing medical research and the development of new healthcare treatments and technologies. The amount of research and development funding is increasing due to factors including rising healthcare demands, technological advancements, and government initiatives. Research and development funding is used to advance the development of rixubis, a treatment for hemophilia B, by supporting clinical trials and enhancing therapeutic options for patients. For instance, in May 2023, according to the Congressional Research Service, a US-based government agency, research and development funding is projected to reach $209.7 billion in FY2024, reflecting an increase of $8.9 billion (4.4%) from the estimated $200.8 billion in FY2023. Therefore, the increasing amount of healthcare research and development funding is driving the growth of the rixubis market.

Global Rixubis Market Major Players

Major companies operating in the rixubis market are Takeda Pharmaceutical Company

Regional Analysis For The Global Rixubis Market

North America was the largest region in the rixubis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rixubis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rixubis market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Rixubis Market?

The rixubis market consists of sales of products such as lyophilized powder and single-use vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rixubis Industry?

The rixubis market research report is one of a series of new reports from The Business Research Company that provides rixubis market statistics, including rixubis industry global market size, regional shares, competitors with rixubis market share, detailed rixubis market segments, market trends and opportunities, and any further data you may need to thrive in the rixubis industry. This rixubis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Rixubis Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The rixubis market covered in this report is segmented –
1) By Type: Recombinant Factor IX; Plasma-derived Factor IX
2) By Indication: Routine Prophylaxis; Treatment Of Bleeding Episodes; Peri-Operative Management
3) By Application: Hemophilia B Treatment; Surgical Procedures
4) By End User: Pediatric; Adult; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Takeda Pharmaceutical Company
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Rixubis Market Characteristics

    3. Rixubis Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Rixubis Market Trends And Strategies

    5. Rixubis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Rixubis Growth Analysis And Strategic Analysis Framework

    6.1. Global Rixubis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Rixubis Market Growth Rate Analysis

    6.4. Global Rixubis Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Rixubis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Rixubis Total Addressable Market (TAM)

    7. Global Rixubis Pricing Analysis & Forecasts

    8. Rixubis Market Segmentation

    8.1. Global Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Recombinant Factor IX

    Plasma-derived Factor IX

    8.2. Global Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Routine Prophylaxis

    Treatment Of Bleeding Episodes

    Peri-Operative Management

    8.3. Global Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hemophilia B Treatment

    Surgical Procedures

    8.4. Global Rixubis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Pediatric

    Adult

    Geriatric

    9. Global Rixubis Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Rixubis Market Regional And Country Analysis

    10.1. Global Rixubis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Rixubis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Rixubis Market

    11.1. Asia-Pacific Rixubis Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Rixubis Market

    12.1. China Rixubis Market Overview

    12.2. China Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Rixubis Market

    13.1. India Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Rixubis Market

    14.1. Japan Rixubis Market Overview

    14.2. Japan Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Rixubis Market

    15.1. Australia Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Rixubis Market

    16.1. South Korea Rixubis Market Overview

    16.2. South Korea Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Rixubis Market

    17.1. Western Europe Rixubis Market Overview

    17.2. Western Europe Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Rixubis Market

    18.1. UK Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Rixubis Market

    19.1. Germany Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Rixubis Market

    20.1. France Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Rixubis Market

    21.1. Eastern Europe Rixubis Market Overview

    21.2. Eastern Europe Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Rixubis Market

    22.1. North America Rixubis Market Overview

    22.2. North America Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Rixubis Market

    23.1. USA Rixubis Market Overview

    23.2. USA Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Rixubis Market

    24.1. Canada Rixubis Market Overview

    24.2. Canada Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Rixubis Market

    25.1. South America Rixubis Market Overview

    25.2. South America Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Rixubis Market

    26.1. Middle East Rixubis Market Overview

    26.2. Middle East Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Rixubis Market

    27.1. Africa Rixubis Market Overview

    27.2. Africa Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Rixubis Market Competitive Landscape And Company Profiles

    28.1. Rixubis Market Competitive Landscape

    28.2. Rixubis Market Company Profiles

    28.2.1. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

    29. Global Rixubis Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Rixubis Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Rixubis Market

    32. Recent Developments In The Rixubis Market

    33. Rixubis Market High Potential Countries, Segments and Strategies

    33.1 Rixubis Market In 2029 - Countries Offering Most New Opportunities

    33.2 Rixubis Market In 2029 - Segments Offering Most New Opportunities

    33.3 Rixubis Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Rixubis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Rixubis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Rixubis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Takeda Pharmaceutical Company Financial Performance
  • Table 61: 0 Financial Performance
  • Table 62: 0 Financial Performance
  • Table 63: 0 Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Rixubis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Rixubis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Rixubis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Rixubis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Rixubis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Rixubis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Takeda Pharmaceutical Company Financial Performance
  • Figure 61: 0 Financial Performance
  • Figure 62: 0 Financial Performance
  • Figure 63: 0 Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the stem cell therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the regenerative medicine for cartilage market research report 2022 with industry size, share, segments and market growth

Read More

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025 – By Product (Endoscopic Thermal Devices, Other Products), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End User (Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bleeding Disorders Treatment Global Market Report 2025 – By Treatment (Desmopressin (DDAVP), Hormone Replacement Therapy, Contraceptives, Anti-Fibrinolytic or Clot-Stabilizing Drugs, Fibrin Sealants, Drugs Applied To Cuts, Pipeline Analysis), By Disease Type (Hemophilia A, Hemophilia B, Von willebrand disease, Liver disease, Other Disease Types), By End User (Hospitals, Clinics, Specialty Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cyclic Heavy Menstrual Bleeding Global Market Report 2025 – By Type (Polymenorrhea, Oligomenorrhea, Metrorrhagia), By Treatment Type (Medication, Hormonal Therapy, Surgery), By Route of Administration (Oral, Parenteral), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acquired Hemophilia Treatment Global Market Report 2025 – By Treatment (On-Demand, Prophylaxis), By Type (Hemophilia A, Hemophilia B, Hemophilia C, Other Types), By End User (Hospitals, Clinic, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Transfusion Diagnostics Global Market Report 2025 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Stem Cell/Cord Blood Banking Global Market Report 2025 – By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type (Public, Private), By Application (Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Glucose Meters Global Market Report 2025 – By Product type (Electrode Type Blood Glucose Meter, Photoelectric Blood Glucose Meter), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Rixubis market?

Rixubis is a recombinant factor IX therapy developed for the treatment and prevention of bleeding episodes in individuals with hemophilia B. It is designed to replace the missing or deficient factor IX in patients, helping to achieve better bleeding control and improved quality of life. For further insights on the Rixubis market, request a sample here

How will the Rixubis market drivers and restraints affect the market dynamics? What forces will shape the Rixubis industry going forward?

The Rixubis market major growth driver - Growing Hemophilia Cases Increase Need For Effective Bleeding Disorder Treatments. For further insights on the Rixubis market, request a sample here

What is the forecast market size or the forecast market value of the Rixubis market?

The Rixubis market size has grown strongly in recent years. The rixubis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rise in the prevalence of hemophilia B, an increase in awareness about genetic bleeding disorders, growth in the number of diagnostic centers, improved healthcare infrastructure, and early adoption of replacement therapies. The rixubis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing demand for recombinant therapies, increasing focus on personalized medicine, government initiatives to improve rare disease management, improved affordability of advanced treatments, and enhanced diagnostic accuracy for genetic disorders. Major trends in the forecast period include increasing adoption of long-acting recombinant products, growing preference for home-based treatment solutions, advancements in delivery mechanisms, development of cost-effective biosimilars, and integration of digital health tools for patient monitoring. For further insights on the Rixubis market, request a sample here

How is the Rixubis market segmented?

The rixubis market covered in this report is segmented –
1) By Type: Recombinant Factor IX; Plasma-derived Factor IX
2) By Indication: Routine Prophylaxis; Treatment Of Bleeding Episodes; Peri-Operative Management
3) By Application: Hemophilia B Treatment; Surgical Procedures
4) By End User: Pediatric; Adult; Geriatric For further insights on the Rixubis market, request a sample here

Which region has the largest share of the Rixubis market? What are the other regions covered in the report?

North America was the largest region in the rixubis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rixubis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Rixubis market, request a sample here.

Who are the major players in the Rixubis market?

Major companies operating in the rixubis market are Takeda Pharmaceutical Company . For further insights on the Rixubis market, request a sample here.

What are the key trends in the Rixubis market?

Major trends in the Rixubis market include . For further insights on the Rixubis market, request a sample here.

What are the major opportunities in the Rixubis market? What are the strategies for the Rixubis market?

For detailed insights on the major opportunities and strategies in the Rixubis market, request a sample here.

How does the Rixubis market relate to the overall economy and other similar markets?

For detailed insights on Rixubis's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Rixubis industry?

For detailed insights on the mergers and acquisitions in the Rixubis industry, request a sample here.

What are the key dynamics influencing the Rixubis market growth? SWOT analysis of the Rixubis market.

For detailed insights on the key dynamics influencing the Rixubis market growth and SWOT analysis of the Rixubis industry, request a sample here.